QSAR-based virtual screening: advances and applications in drug discovery; Discovery of new anti-schistosomal hits by integration of QSAR-based virtual screening and high content screening; QSAR Modeling of SARS‐CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS …; 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models.; QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni; Learning from history: do not flatten the curve of antiviral research!; Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum; Advances in methods for predicting phase I metabolism of polyphenols.; Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening; In silico chemogenomics drug repositioning strategies for neglected tropical diseases; Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study; QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities; Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2; Computer-aided identification of novel anti-paracoccidioidomycosis compounds; Conserved coronavirus proteins as targets of broad-spectrum antivirals; QSAR-based virtual screening: advances and applications in drug discovery. Front Pharmacol 9: 1275; Computational drug discovery for the Zika virus; Compact walks: Taming knowledge-graph embeddings with domain-and task-specific pathways; Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents; QSAR-based virtual screening: advances and applications in drug discovery. Front Pharmacol. 2018; 9: 1275
